Description: NovelStem International Corp. focuses on developing and commercialization of diagnostic technology that can predict patients' resistance to chemotherapy allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018 as a result of its business focus shift from advertising services to stem cell-based diagnostics for cancer chemotherapies. The company was founded in 1993 and is headquartered in Boca Raton, Florida.
Home Page: www.novelstem.com
2255 Glades Road
Boca Raton,
FL
33431
United States
Phone:
410 654 3315
Officers
| Name | Title |
|---|---|
| Mr. Mitchell Rubenstein | Co-Founder & Director |
| Mr. Jan H. Loeb | Exec. Chairman |
| Ms. Christine Jenkins | CFO & Sec. |
| Mr. David Collins | Investor Relations Firm, Catalyst IR |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 1.1875 |
| Price-to-Book MRQ: | 0.5082 |
| Price-to-Sales TTM: | 32.159 |
| IPO Date: | 1993-11-12 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |